Solvent-free cascade reaction: direct multicomponent assembling of 2-amino-4H-chromene scaffold from salicylaldehyde, malononitrile or cyanoacetate and nitroalkanes

Tetrahedron

Volumn 66, Issue 23, 2010, Pages 4043-4048

  Elinson, Michail N ^a   Ilovaisky, Alexey I ^a   Merkulova, Valentina M ^a   Belyakov, Pavel A ^a   Chizhov, Alexander O ^a   Nikishin, Gennady I ^a  

^a N D ZELINSKY INSTITUTE OF ORGANIC CHEMISTRY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4 (1 METHYL 1 NITRO 4 OXOPENTYL) 4H CHROMENE 3 CARBONITRILE; 2 AMINO 4 (1 NITRO 4 OXOPENTYL) 4H CHROMENE 3 CARBONITRILE; 2 AMINO 4 (1 NITROPROPYL) 4H CHROMENE 3 CARBONITRILE; 2 AMINO 4 (NITROMETHYL) 4H CHROMENE 3 CARBONITRILE; ACETIC ACID; CHROMENE DERIVATIVE; CYANOACETIC ACID; MALONONITRILE; METHYL 2 AMINO 4 (1 METHYL 1 NITRO 4 OXOPENTYL) 4H CHROMENE 3 CARBOXYLIC ACID; METHYL 2 AMINO 4 (1 METHYL 1 NITROETHYL) 4H CHROMENE 3 CARBOXYLIC ACID; METHYL 2 AMINO 4 (1 NITRO 4 OXOPENTYL) 4H CHROMENE 3 CARBOXYLIC ACID; METHYL 2 AMINO 4 (1 NITROCYCLOHEXYL) 4H CHROMENE 3 CARBOXYLIC ACID; METHYL 2 AMINO 4 (1 NITROETHYL) 4H CHROMENE 3 CARBOXYLIC ACID; METHYL 2 AMINO 4 (1 NITROPROPYL) 4H CHROMENE 3 CARBOXYLIC ACID; METHYL 2 AMINO 4 (2 METHOXY 1 NITRO 2 OXOETHYL) 4H CHROMENE 3 CARBOXYLIC ACID; METHYL 2 AMINO 4 (4 METHOXY 1 METHYL 1 NITRO 4 OXOBUTYL) 4H CHROMENE 3 CARBOXYLIC ACID; METHYL 2 AMINO 4 (NITROMETHYL) 4H CHROMENE 3 CARBOXYLIC ACID; METHYL 2 AMINO 4 [NITRO(PHENYL)METHYL] 4H CHROMENE 3 CARBOXYLIC ACID; METHYL 4 (2 AMINO 3 CYANO 4H CHROMEN 4 YL) 4 NITROPENTANOATE; NITROALKANE; SALICYLALDEHYDE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CHEMICAL REACTION; ONE POT SYNTHESIS; PRIORITY JOURNAL; SOLVENT FREE CASCADE REACTION;

EID: 77953122591     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2010.04.024     Document Type: Article

References (38)

1. Thompson L.A. Curr. Opin. Chem. Biol. 4 (2000) 324-337
2. Nefzi A., Ostresh J.M., and Houghten R.A. Chem. Rev. 97 (1997) 449-472
3. Weber L. Drug Disc. Today 7 (2002) 143-147
4. Dömling A. Curr. Opin. Chem. Biol. 6 (2002) 306-313
5. The term 'privileged scaffolds or structures' was originally introduced by Merck researchers in their work on benzodiazepins:. Evans B.E., Rittle K.E., Bock G., DiPardo R.M., Freidinger R.M., Whitter W.L., Lundell G.F., Veber D.F., Anderson P.S., Chang R.S.L., Lotti V.G., Cerino D.J., Chen T.B., Kling P.J., Kunkel K.A., Springer J.P., and Hirshfield J. J. Med. Chem. 31 (1988) 2235-2246 for reviews see:
6. DeSimone R.W., Currie K.S., Mitchell S.A., Darrow J.W., and Pippin D.A. Comb. Chem. High Throughput Screen. 7 (2004) 473-493
7. Triggle D.J. Cell. Mol. Neurobiol. 23 (2003) 293-303
8. Patchett A.A., and Nargund R.P. Annu. Rep. Med. Chem. 35 (2000) 289-298
9. Poupaert J., Carato P., and Colacino E. Curr. Med. Chem. 12 (2005) 877-885
10. For examples of natural compounds containing the chromene fragment, see:
11. In: Harborne J.B. (Ed). The Flavonoids-Advances in Research (1988), Chapman & Hall, London, UK
12. Parmar V.S., Jain S.C., Bisht K.S., Jain R., Taneja P., Jha A., Tyagi O.D., Prasad A.K., Wengel J., Olsen C.E., and Boll P.M. Phytochemistry 46 (1997) 597-674
13. Gill M. Aust. J. Chem. 48 (1995) 1-26
14. Bohm B.A., Choy J.B., and Lee A.Y.-M. Phytochemistry 28 (1989) 501-504
15. Iacobucci G.A., and Sweeny J.G. Tetrahedron 39 (1983) 3005-3038
16. For recent reports, see:
17. Sun W., Cama L.J., Birzin E.T., Warrier S., Locco L., Mosley R., Hammond M.L., and Rohrer S.P. Bioorg. Med. Chem. Lett. 16 (2006) 1468-1472
18. Stachulski A.V., Berry N.G., Low A.C.L., Moores S., Row E., Warhurst D.C., Adagu I.S., and Rossignol J.-F. J. Med. Chem. 49 (2006) 1450-1454
19. Garino C., Bihel F., Pietrancosta N., Laras Y., Quéléver G., Woo I., Klein P., Bain J., Boucher J.-L., and Kraus J.-L. Bioorg. Med. Chem. Lett. 15 (2005) 135-138
20. Bonsignore L., Loy G., Secci D., and Calignano A. Eur. J. Med. Chem. 28 (1993) 517-520
21. Foye W.O. Prinicipi di Chemico Farmaceutica (1991), Piccin, Padova, PD p 416
22. Witte, E.C.; Neubert, P.; Roesch, A. Ger. Offen. DE 3427985, 1986.
23. Chem. Abstr. 104 (1986) 224915f
24. Andreani L.L., and Lapi E. Boll. Chim. Farm. 99 (1960) 583-587
25. Skommer J., Wlodkowic D., Mättö M., Eray M., and Pelkonen J. Leukemia Res. 30 (2006) 322-331, and references therein
26. Kemnitzer W., Kasibhatla S., Jiang S., Zhang H., Zhao J., Jia S., Xu L., Crogan-Grundy C., Denis R., Barriault N., Vaillancourt L., Charron S., Dodd J., Attardo G., Labrecque D., Lamothe S., Gourdeau H., Tseng B., Drewe J., and Cai S.X. Bioorg. Med. Chem. Lett. 15 (2005) 4745-4751
27. Gourdeau H., Leblond L., Hamelin B., Desputeau C., Dong K., Kianicka I., Custeau D., Bourdeau C., Geerts L., Cai S.X., Drewe J., Labrecque D., Kasibhatla S., and Tseng B. Mol. Cancer Ther. 3 (2004) 1375-1384
28. Elinson M.N., Dorofeev A.S., Miloserdov F.M., Ilovaisky A.I., Feducovich S.K., Belyakov P.A., and Nikishin G.I. Adv. Synth. Catal. 350 (2008) 591-601
29. Tanaka K. Solvent-free Organic Synthesis (2003), Wiley-VCH, Weinheim
30. Ananikov V.P. Cent. Eur. J. Chem. (CEJC) 2 (2004) 196-213
31. Patai S., and Israeli Y. J. Chem. Soc. (1960) 2025-2030
32. ÓCallaghan C.N., McMurry T.B., and ÓBrein J.E. J. Chem. Soc., Perkin Trans. 1 4 (1995) 417-420
33. 'Towards the ideal synthesis'. Wender P.A., Handy S.T., and Wright D.L. Chem. Ind. (1997) 765-769
34. Kornblum N., Larson H.O., Blackwood R.K., Mooberry D.D., Oliveto E.P., and Graham G.E. J. Am. Chem. Soc. 70 (1956) 1497-1501
35. Lewellyn M.E., and Tarbell D.S. J. Org. Chem. 39 (1974) 1407-1410
36. Ballini R., and Bosica G. Tetrahedron Lett. 37 (1996) 8027-8030
37. Ballini R., and Bosica G. Eur. J. Org. Chem. (1998) 355-357
38. Roudier J.F., and Foucaud A. Synthesis (1984) 159-160